Abstract
[3H]Serotonin (5-HT) binds to membrane preparations of rat brain in a saturable fashion and with substrate specificity and regional variations consistent with its binding to the postsynaptic serotonin receptor. The dissociation constant for [3H]5-HT binding is about 8 nM, and the total number of 5-HT binding sites in the brain is 16 pmoles/g of tissue, wet weight. There is considerable structural specificity in the affinity of various tryptamines for the [3H]5-HT binding sites, with a crucial role played by the 5-hydroxy substituent. d-[3H]Lysergic acid diethylamide (LSD) binding sites have substrate specificity requirements similar to the [3H]5-HT binding sites, but the 5-hydroxy substituent is less critical. 5-HT and related agonists have about 100 times more affinity for 5-HT than LSD binding sites, while classical 5-HT antagonists have 4-100 times greater affinity for LSD binding sites. LSD itself has a similar affinity for 5-HT and LSD binding sites. Raphe lesions which result in degeneration of 5-HT neurons do not lower [3H]5-HT binding, indicating that binding does not take place to presynaptic 5-HT neurons. Regional variations in serotonin and LSD binding are fairly similar. Highest binding occurs in the corpus striatum, hippocampus, and cerebral cortex, with lowest binding in the cerebellum. The ontogeny of 5-HT and LSD binding sites is nearly identical and does not appear to depend on functionally intact presynaptic 5-HT neuronal input.
ACKNOWLEDGMENTS We gratefully acknowledge the dedicated technical assistance of Gregory Mack.
- Copyright © 1976 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|